These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 15191731

  • 1. [Defect of TCR-mediated signal pathway of T cells in IDDM patients].
    Li HM, Zhong RQ, Yu JP, Cao LN, Kong XT, Chen WF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):222-4. PubMed ID: 15191731
    [Abstract] [Full Text] [Related]

  • 2. Constitutive impaired TCR/CD3-mediated activation of T cells in IDDM patients co-exist with normal co-stimulation pathways.
    Nervi S, Atlan-Gepner C, Fossat C, Vialettes B.
    J Autoimmun; 1999 Sep; 13(2):247-55. PubMed ID: 10479393
    [Abstract] [Full Text] [Related]

  • 3. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T, Allison JP, Davidson WF.
    J Immunol; 1993 Jul 15; 151(2):597-609. PubMed ID: 7687618
    [Abstract] [Full Text] [Related]

  • 4. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D, Lazarus AH, Crow AR, Hadzija M, Delovitch TL.
    J Immunol; 1991 Jun 01; 146(11):3763-71. PubMed ID: 1827815
    [Abstract] [Full Text] [Related]

  • 5. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.
    Arreaza GA, Cameron MJ, Jaramillo A, Gill BM, Hardy D, Laupland KB, Rapoport MJ, Zucker P, Chakrabarti S, Chensue SW, Qin HY, Singh B, Delovitch TL.
    J Clin Invest; 1997 Nov 01; 100(9):2243-53. PubMed ID: 9410902
    [Abstract] [Full Text] [Related]

  • 6. Cytokine- and costimulation-mediated therapy of IDDM.
    Cameron MJ, Arreaza GA, Delovitch TL.
    Crit Rev Immunol; 1997 Nov 01; 17(5-6):537-44. PubMed ID: 9419441
    [Abstract] [Full Text] [Related]

  • 7. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA, Ledbetter JA, Lee K, June CH, Thompson CB.
    J Immunol; 1990 Mar 01; 144(5):1646-53. PubMed ID: 2155264
    [Abstract] [Full Text] [Related]

  • 8. CD28-induced cytokine production and proliferation by thymocytes are differentially regulated by the p59fyn tyrosine kinase.
    Ong CJ, Lim AS, Teh HS.
    J Immunol; 1997 Sep 01; 159(5):2169-76. PubMed ID: 9278304
    [Abstract] [Full Text] [Related]

  • 9. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
    Soares LR, Rivas A, Tsavaler L, Engleman EG.
    J Immunol; 1997 Aug 01; 159(3):1115-24. PubMed ID: 9233604
    [Abstract] [Full Text] [Related]

  • 10. Mycobacterial antigen(s) induce anergy by altering TCR- and TCR/CD28-induced signalling events: insights into T-cell unresponsiveness in leprosy.
    Dagur PK, Sharma B, Kumar G, Khan NA, Katoch VM, Sengupta U, Joshi B.
    Mol Immunol; 2010 Feb 01; 47(5):943-52. PubMed ID: 20018378
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD28-mediated activation of resting human T cells without costimulation of the CD3/TCR complex.
    Siefken R, Kurrle R, Schwinzer R.
    Cell Immunol; 1997 Feb 25; 176(1):59-65. PubMed ID: 9070318
    [Abstract] [Full Text] [Related]

  • 13. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
    June CH, Ledbetter JA, Lindsten T, Thompson CB.
    J Immunol; 1989 Jul 01; 143(1):153-61. PubMed ID: 2543699
    [Abstract] [Full Text] [Related]

  • 14. A CD28-associated signaling pathway leading to cytokine gene transcription and T cell proliferation without TCR engagement.
    Siefken R, Klein-Hessling S, Serfling E, Kurrle R, Schwinzer R.
    J Immunol; 1998 Aug 15; 161(4):1645-51. PubMed ID: 9712026
    [Abstract] [Full Text] [Related]

  • 15. Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists.
    Lühder F, Huang Y, Dennehy KM, Guntermann C, Müller I, Winkler E, Kerkau T, Ikemizu S, Davis SJ, Hanke T, Hünig T.
    J Exp Med; 2003 Apr 21; 197(8):955-66. PubMed ID: 12707299
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Direct involvement of CD7 (gp40) in activation of TcR gamma/delta+ T cells.
    Carrel S, Salvi S, Rafti F, Favrot M, Rapin C, Sekaly RP.
    Eur J Immunol; 1991 May 21; 21(5):1195-200. PubMed ID: 1709867
    [Abstract] [Full Text] [Related]

  • 18. CD28-mediated costimulation is necessary for the activation of T cell receptor-gamma delta+ T lymphocytes.
    Sperling AI, Linsley PS, Barrett TA, Bluestone JA.
    J Immunol; 1993 Dec 01; 151(11):6043-50. PubMed ID: 8245449
    [Abstract] [Full Text] [Related]

  • 19. Defective T cell receptor/CD3 complex signaling in human type I diabetes.
    De Maria R, Todaro M, Stassi G, Di Blasi F, Giordano M, Galluzzo A, Giordano C.
    Eur J Immunol; 1994 Apr 01; 24(4):999-1002. PubMed ID: 8149968
    [Abstract] [Full Text] [Related]

  • 20. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response.
    Lucas PJ, Negishi I, Nakayama K, Fields LE, Loh DY.
    J Immunol; 1995 Jun 01; 154(11):5757-68. PubMed ID: 7751626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.